[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Sight Sciences Inc (SGHT)

Sight Sciences Inc (SGHT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 463,290
  • Shares Outstanding, K 55,088
  • Annual Sales, $ 77,360 K
  • Annual Income, $ -38,430 K
  • EBIT $ -28 M
  • EBITDA $ -26 M
  • 60-Month Beta 2.38
  • Price/Sales 5.96
  • Price/Cash Flow N/A
  • Price/Book 8.61

Options Overview Details

View History
  • Implied Volatility 162.63% (+77.39%)
  • Historical Volatility 79.88%
  • IV Percentile 33%
  • IV Rank 6.78%
  • IV High 1,256.56% on 02/18/26
  • IV Low 83.02% on 08/21/26
  • Expected Move (DTE 21) 0.98 (11.43%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 126
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 1,997
  • Open Int (30-Day) 1,263
  • Expected Range 7.57 to 9.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.13
  • Number of Estimates 3
  • High Estimate $-0.13
  • Low Estimate $-0.14
  • Prior Year $-0.16
  • Growth Rate Est. (year over year) +18.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.05 +69.31%
on 08/03/26
8.85 -3.39%
on 08/19/26
+3.25 (+61.32%)
since 07/28/26
3-Month
4.22 +102.85%
on 06/03/26
8.85 -3.39%
on 08/19/26
+3.49 (+68.97%)
since 05/28/26
52-Week
3.19 +168.03%
on 10/10/25
9.24 -7.43%
on 12/26/25
+4.51 (+111.63%)
since 08/28/25

Most Recent Stories

More News
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease

MENLO PARK, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies...

SGHT : 8.55 (+1.66%)
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease

MENLO PARK, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies...

SGHT : 8.55 (+1.66%)
Sight Sciences Reports Second Quarter 2026 Financial Results

Raises Full-Year 2026 Revenue Guidance and Reduces Adjusted Operating Expense Guidance

SGHT : 8.55 (+1.66%)
Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.55 (+1.66%)
Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.55 (+1.66%)
Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System

MENLO PARK, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies...

SGHT : 8.55 (+1.66%)
Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System

New system expands the Company’s leadership in interventional glaucoma with the first FDA cleared MIGS device for single pass canaloplasty with TruSync™...

SGHT : 8.55 (+1.66%)
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

MENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.55 (+1.66%)
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

MENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company...

SGHT : 8.55 (+1.66%)
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (

SGHT : 8.55 (+1.66%)

Business Summary

Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.

See More

Key Turning Points

3rd Resistance Point 8.86
2nd Resistance Point 8.70
1st Resistance Point 8.63
Last Price 8.55
1st Support Level 8.40
2nd Support Level 8.24
3rd Support Level 8.17

See More

52-Week High 9.24
Last Price 8.55
Fibonacci 61.8% 6.93
Fibonacci 50% 6.21
Fibonacci 38.2% 5.50
52-Week Low 3.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.